Similar Papers

Paper Title
Journal
Date
Author
Product Inhibition of UDP-Glucuronosyltransferase (UGT) Enzymes by UDP Obfuscates the Inhibitory Effects of UGT Substrates
Ryoichi Fujiwara ... Miki Nakajima
Drug Metabolism and Disposition | VOL. 36
Ryoichi Fujiwara, et. al.Ryoichi Fujiwara ... Miki Nakajima
12 Nov 2007
Identification of Human UDP-Glucuronosyltransferase Isoform(s) Responsible for the Glucuronidation of 2-(4-Chlorophenyl)-5-(2-Furyl)-4-Oxazoleacetic Acid (TA-1801A)
Hidefumi Kaji ... Toshiyuki Kume
Drug Metabolism and Pharmacokinetics | VOL. 20
Hidefumi Kaji, et. al.Hidefumi Kaji ... Toshiyuki Kume
01 Jan 2004
Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Yuichiro Watanabe ... Tsuyoshi Yokoi
Drug Metabolism and Disposition | VOL. 30
Yuichiro Watanabe, et. al.Yuichiro Watanabe ... Tsuyoshi Yokoi
01 Dec 2002
Validation of Serotonin (5-Hydroxtryptamine) as an in Vitro Substrate Probe for Human UDP-Glucuronosyltransferase (UGT) 1A6
Soundararajan Krishnaswamy ... Lisa L Von Moltke
Drug Metabolism and Disposition | VOL. 31
Soundararajan Krishnaswamy, et. al.Soundararajan Krishnaswamy ... Lisa L Von Moltke
01 Jan 2003
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
India’s organ transplant paradox: women donate the most and receive the least
Rupsa Chakraborty
BMJ | VOL. 388
Rupsa ChakrabortyRupsa Chakraborty
07 Feb 2025
Political changes and healthcare in Canada
Colleen M Flood ... Greg Marchildon
BMJ | VOL. 388
Colleen M Flood, et. al.Colleen M Flood ... Greg Marchildon
07 Feb 2025
Police consider manslaughter charges in 200 cases of harm and death at Brighton hospital
Clare Dyer
BMJ | VOL. 388
Clare DyerClare Dyer
07 Feb 2025
Malaria: African leaders pledge to tackle funding gap amid uncertainty over foreign aid
Gilbert Nakweya
BMJ | VOL. 388
Gilbert NakweyaGilbert Nakweya
07 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.